Interspecialty Differences in Physicians' Attitudes,Beliefs,and Reasons for Withdrawing or Withholding Hypercalcemia Treatment in Terminally Ill Patients

Bower M , Cos S : Endocrine and metabolic complications of advanced cancer. Oxford Textbook for Palliative Medicine 4th edition. Oxford University Press: New York, 2010.

Ernst D , Wolch G : Hypercalcemia. In: Bruera E , Higginson I , Ripamonti C , von Gunten F (eds.): Textbook of Palliative Medicine. Hodder Arnold Press: London, 2006, pp. 799–816.

Lumachi F , Brunello A , Roma A , Basso U : Cancer-induced hypercalcemia. Anticancer Res, 2009; 29:1551–1555.

Saunders Y , Ross JR , Broadley KE , et al.: Systematic review of bisphosphonates for hypercalcaemia of malignancy. Palliat Med, 2004; 18:418–431.

Lawlor PG , Gagnon B , Mancini IL , et al.: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med, 2000; 160:786–794.

Morita T , Tei Y , Tsunoda J , et al.: Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage, 2001; 22:997–1006.

Body JJ , Dumon JC : Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: Dose-response relationship and influence of tumour type. Ann Oncol, 1994; 5:359–363.

Nussbaum SR , Younger J , Vandepol CJ , et al.: Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages. Am J Med, 1993; 95:297–304.

Boisaubin E , Lynch G , Dresser R : Hypercalcemia of advanced malignancy: Decision making and the quality of death. Am J Med Sci, 1991; 301:314–318.

Keating N , Landrum M , Rogers S : Physician factors associated with discussions about end-of-life care. Cancer, 2010; 116:998–1006.

Morita T , Akechi T , Sugawara Y , et al.: Practices and attitudes of Japanese oncologists and palliative care physicians concerning terminal sedation: A nationwide survey. J Clin Oncol, 2002; 20:758–764.

Morita T . Attitudes of Japanese physicians toward terminal dehydration: A nationwide survey. J Clin Oncol, 2002; 20:4699–4704.

Reilly BM , Magnussen CR , Ross J , et al.: Can we talk? Inpatient discussions about advance directives in a community hospital. Attending physicians' attitudes, their inpatients' wishes, and reported experience. Arch Intern Med, 1994; 154:2299–2308.

Shimada A , Mori I , Maeda I , et al.: Physicians' attitude toward recurrent hypercalcemia in terminally ill cancer patients. Support Care Cancer, 2015; 23:177–183.

Body JJ , Louviaux I , Dumon JC : Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia. Support Care Cancer, 2000; 8:398–404.

Legrand SB : Modern management of malignant hypercalcemia. Am J Hosp Palliat Care, 2011; 28:515–517.

Mundy GR , Guise TA : Hypercalcemia of malignancy. Am J Med, 1997; 703:134–145.